E. Dokukina

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

V. Mazurov, O. Moiseeva, M. Gilyarov, 2021, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

POS1214 THE DYNAMICS OF INFLAMMATORY MARKERS IN COVID-19 PATIENTS TREATED WITH LEVILIMAB

V. Mazurov, O. Moiseeva, M. Gilyarov, 2021, Annals of the Rheumatic Diseases.

FRI0391 NETAKIMAB IMPROVES PATIENT-RELATED OUTCOMES IN PATIENTS WITH RADIOLOGICAL AXIAL SPONDYLOARTHRITIS: RESULTS FROM RANDOMISED PHASE 3 TRIAL (ASTERA)

V. Mazurov, T. Dubinina, S. Erdes, 2019, Spondyloarthritis – treatment.

AB0791 NETAKIMAB REDUCES SKIN MANIFESTATIONS OF PSORIATIC ARTHRITIS: RESULTS OF SUBANALYSIS FROM A DOUBLE-BLIND RANDOMIZED PHASE 3 STUDY (PATERA)

V. Mazurov, A. Samtsov, M. Kokhan, 2020 .

FRI0346 EFFICACY OF NETAKIMAB IN THE TREATMENT OF AXIAL DISEASE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS OF SUBANALYSIS FROM A DOUBLE-BLIND RANDOMIZED PHASE 3 TRIAL (PATERA)

V. Mazurov, A. Samtsov, M. Kokhan, 2020, Annals of the Rheumatic Diseases.

OP0226 NETAKIMAB DECREASES DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PHASE 3 CLINICAL TRIAL (PATERA)

V. Mazurov, A. Samtsov, M. Kokhan, 2020, Annals of the Rheumatic Diseases.

OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study

V. Mazurov, T. Dubinina, S. Erdes, 2018, WEDNESDAY, 13 JUNE 2018.

A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study

V. Mazurov, L. Denisov, O. Nesmeyanova, 2019, Rheumatology International.

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR

V. Mazurov, A. Lila, M. Korolev, 2023, Rheumatology Science and Practice.